Koppel Adam

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 24% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Koppel Adam's trades of Kailera Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-20 2026-04-20
B Purchase
19,285 -16.8%
235.50
US$3,727,967 		19,285 -16.8% 235.50 US$3,727,967
2023-10-18 2023-10-16
B Purchase
84,423 -3.5%
179.44
US$1,900,206 		84,423 -3.5% 179.44 US$1,900,206
2020-12-14 2020-12-10
S Sale
12,270 -15.3%
172.49
US$828,607 		12,270 -15.3% 172.49 US$828,607
2020-11-12 2020-11-09
B Purchase
332,293 +0.6%
10.30
US$3,422,618 		332,293 +0.6% 10.30 US$3,422,618
2020-10-29 2020-10-27
B Purchase
10,000,000 +19.9%
10.00
US$100,000,000 		10,000,000 +19.9% 10.00 US$100,000,000
2020-01-16 2020-01-14
US Aptinyx Inc (APTX)
B Purchase
3,333,333 +149.8%
3.00
US$9,999,999 		3,333,333 +149.8% 3.00 US$9,999,999